May 13, 2019 Cellectar Receives FDA Fast Track Designation for CLR 131 in Relapsed or Refractory Multiple Myeloma Learn More
May 6, 2019 Cellectar Reports First Quarter 2019 Financial Results and Provides a Corporate Update Learn More
Mar 19, 2019 FDA Grants Exemption to Import Alert for Cellectar’s CLR 131 in Pediatric and Adolescent Patients Learn More
Feb 26, 2019 Cellectar Reports Financial Results for Year Ended December 31, 2018 and Provides a Corporate Update Learn More